BioCentury

12:22 AM GMT, Oct 30, 2012
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Company News

Titan seeks approval for Probuphine

Titan Pharmaceuticals Inc. (OTCBB:TTNP) submitted an NDA to FDA for Probuphine buprenorphine to

Read the full 135 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.